Status:
COMPLETED
Trial of OTD70DERM® in Radio-dermatitis Induced by Radiotherapy-Erbitux®
Lead Sponsor:
Groupe Oncologie Radiotherapie Tete et Cou
Conditions:
Head and Neck Carcinoma
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The aim of this randomized trial is to compare the rate of radio-dermatitis grade 2+ (NCI-CTC V3.0) in patients receiving radiotherapy+Erbitux+placebo versus in patients receiving radiotherapy+Erbitux...
Eligibility Criteria
Inclusion
- Head and neck carcinoma treated by radiotherapy (70Gy) plus Erbitux
Exclusion
- IMRT; Concomitant chemotherapy
Key Trial Info
Start Date :
August 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2014
Estimated Enrollment :
76 Patients enrolled
Trial Details
Trial ID
NCT01228565
Start Date
August 1 2010
End Date
May 1 2014
Last Update
March 24 2015
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
CHI Creteil
Créteil, France, 94010
2
Centre de Forcilles
Ferolles Attily, France, 77150
3
CLCC Nantes
Nantes, France, 44085
4
CHU Pitie Salpetriere
Paris, France, 75013